Alvotech (ALVO) Change in Receivables (2021 - 2026)
Alvotech (ALVO) posted Change in Receivables of $21.9 million for Q1 2026, up 410.79% on a QoQ basis from -$7.1 million in Q4 2025, and up 142.8% year-over-year from $9.0 million in Q1 2025.
Alvotech (ALVO) Change in Receivables (2021 - 2026) Analysis & Trends
Alvotech's Change in Receivables history runs 6 years deep, the most recent figure standing at $21.9 million for Q1 2026.
- Quarterly Change in Receivables rose 142.8% year-over-year to $21.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $106.1 million (up 172.55% YoY) and the FY2025 annual result came in at $93.2 million, up 178.26% from the prior year.
- Change in Receivables was $21.9 million for Q1 2026 at Alvotech, up from -$7.1 million in the prior quarter.
- Across five years, Change in Receivables topped out at $48.8 million in Q3 2025 and bottomed at -$119.1 million in Q4 2024.
- A 5-year average of -$748533.3 and a median of $3.0 million in 2023 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2024 — Change in Receivables slumped 1331.05% — and 2025, when it soared 22470.0%.
- Alvotech's Change in Receivables stood at -$3.6 million in 2022, then sank by 132.66% to -$8.3 million in 2023, then slumped by 1331.05% to -$119.1 million in 2024, then surged by 94.08% to -$7.1 million in 2025, then soared by 410.79% to $21.9 million in 2026.
- Business Quant data shows ALVO's Change in Receivables at $21.9 million in Q1 2026, -$7.1 million in Q4 2025, and $48.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -78.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 106.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -621.82 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -38.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 126.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 81.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Alvotech | 935.87 Mn | 935.87 Mn | 5.09 Mn | 21.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.92 Mn |
| Mar 31, 2026 | 21.92 Mn |
| Dec 31, 2025 | -7.05 Mn |
| Dec 31, 2025 | -7.05 Mn |
| Sep 30, 2025 | 48.82 Mn |
| Sep 30, 2025 | 48.82 Mn |
| Jun 30, 2025 | 42.38 Mn |
| Jun 30, 2025 | 42.38 Mn |
| Mar 31, 2025 | 9.03 Mn |
| Mar 31, 2025 | 9.03 Mn |
| Dec 31, 2024 | -119.06 Mn |
| Dec 31, 2024 | -119.06 Mn |
| Sep 30, 2024 | 16.10 Mn |
| Sep 30, 2024 | 16.10 Mn |
| Jun 30, 2024 | -52.27 Mn |
| Jun 30, 2024 | -52.27 Mn |
| Mar 31, 2024 | 40,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Dec 31, 2023 | -8.32 Mn |
| Dec 31, 2023 | -8.32 Mn |